Search over 3,000 reports

    Loestrin 24 Fe- Drug Insight, 2017

    Loestrin 24 Fe- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0190
    "Loestrin 24 Fe - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Loestrin 24 Fe. It includes Loestrin 24 Fe`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Loestrin 24 Fe`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Loestrin 24 Fe till 2020. The report also throws light on Loestrin 24 Fe`s market competition and emerging therapies in the same space as Loestrin 24 Fe. A SWOT analysis of Loestrin 24 Fe is also featured.
    * Depending on information availability

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Loestrin 24 Fe in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Loestrin 24 Fe in United States, Europe, China and India
    • The report contains historical and forecasted sales for Loestrin 24 Fe till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Loestrin 24 Fe operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Loestrin 24 Fe

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Loestrin 24 Fe
    • Access to Loestrin 24 Fe`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Loestrin 24 Fe`s patents for the major markets- US and EU
    • Understand Loestrin 24 Fe`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Loestrin 24 Fe
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Loestrin 24 Fe
    • Identify opportunities in the same area as Loestrin 24 Fe with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Loestrin 24 Fe - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Loestrin 24 Fe Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Consulting Services
    About DelveInsight
    Contact Us
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Loestrin 24 Fe, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Loestrin 24 Fe Product Details, United States
    Table 8: Loestrin 24 Fe Product Details, Europe
    Table 9: Loestrin 24 Fe, Historical Global Sales till 2017 (in million USD)
    Table 10: Loestrin 24 Fe, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Loestrin 24 Fe
    Table 12: Loestrin 24 Fe Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Loestrin 24 Fe
    Figure 2: Loestrin 24 Fe, Historical Global Sales till 2017 (in million USD)
    Figure 3: Loestrin 24 Fe, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Loestrin 24 Fe
    Figure 5: API Manufacturers Region wise
    Loestrin 24 Fe

    Loestrin 24 Fe Marketed Drugs Overview

    Loestrin 24 Fe Market Assessment

    Loestrin 24 Fe API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Loestrin 24 Fe US DMF

    Loestrin 24 Fe US Drug Master Files

    Loestrin 24 Fe Active Substance Master File/ EUDMF

    Loestrin 24 Fe Generic players

    Loestrin 24 Fe Patent Expiration

    Loestrin 24 Fe Patent Exclusivity

    Loestrin 24 Fe API Manufacturers

    Loestrin 24 Fe Global Forecasted Sales Figure

    Loestrin 24 Fe API Route of Synthesis

    Loestrin 24 Fe Market sales

    Loestrin 24 Fe SWOT Analysis

    Loestrin 24 Fe Pipeline

    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap